Evidence map›Paper›PMID 28709828›Full record

ArticleBioorganic & medicinal chemistry letters2017

Augmenting the efficacy of anti-cocaine catalytic antibodies through chimeric hapten design and combinatorial vaccination.

Cody J Wenthur, Xiaoqing Cai, Beverly A Ellis, Kim D Janda

Abstract read
In one paragraph

Article in Bioorganic & medicinal chemistry letters, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Cody J WenthurDepartments of Chemistry and Immunology, The Scripps Research Institute, La Jolla, CA 92037, United States.
Xiaoqing CaiDepartments of Chemistry and Immunology, The Scripps Research Institute, La Jolla, CA 92037, United States.
Beverly A EllisDepartments of Chemistry and Immunology, The Scripps Research Institute, La Jolla, CA 92037, United States.
Kim D JandaDepartments of Chemistry and Immunology, The Scripps Research Institute, La Jolla, CA 92037, United States. Electronic address: kdjanda@scripps.edu.

Funding

Immunopharmacotherapy for the Treatment of Cocaine AbuseR01DA008590 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI JANDA, KIM · 1994 to 2016
$6.4M
NIDA NIH HHS R01 DA008590
6 · The paper itself

Abstract

Given the need for further improvements in anti-cocaine vaccination strategies, a chimeric hapten (GNET) was developed that combines chemically-stable structural features from steady-state haptens with the hydrolytic functionality present in transition-state mimetic haptens. Additionally, as a further investigation into the generation of an improved bifunctional antibody pool, sequential vaccination with steady-state and transition-state mimetic haptens was undertaken. While GNET induced the formation of catalytically-active antibodies, it did not improve overall behavioral efficacy. In contrast, the resulting pool of antibodies from GNE/GNT co-administration demonstrated intermediate efficacy as compared to antibodies developed from either hapten alone. Overall, improved antibody catalytic efficiency appears necessary to achieve the synergistic benefits of combining cocaine hydrolysis with peripheral sequestration.

Indexed as

AnimalsAntibodies, CatalyticCatalysisCocaineEnzyme-Linked Immunosorbent AssayHaptensImmunoglobulin GLocomotionRadioimmunoassayVaccinationAntibodies, CatalyticCocaineHaptensImmunoglobulin GAddictionCatalytic antibodyChimeric haptenCocaineVaccine

Identifiers

PMID28709828
PMCPMC5584565

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.